Worldwide Self-Monitoring Blood Glucose Strips Industry Size: Insights, Growth Trends and Forecast

Report ID : 1362072 | Published : February 2025 | Study Period : 2023-2033 | Format : PDF + Excel

The market size of the Self-Monitoring Blood Glucose Strips Industry is categorized based on Type (Blood Glucose Test Strips, Continuous Glucose Monitoring (CGM) Strips) and End User (Hospitals, Homecare, Diabetes Care Centers, Clinics, Others) and Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies, Others) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).

In 2023, the size of the Self-Monitoring Blood Glucose Strips Industry was valued at $7.8 billion and is anticipated to reach $12.5 billion by 2033, expanding at a 4.8% CAGR between 2024 and 2033. The report encompasses multiple segments and provides an analysis of significant trends and factors impacting the market.

The Self Monitoring Blood Glucose Strips market gathered significant attention in the Health care sector especially due to the rise in diabetes prevalence and increased self-care awareness among patients and healthcare practitioners. With the increasing acceptance of glucose monitoring systems, there has been a declarative rise in the glucose blood tests demand. This aspect of the industry is crucial as it aids Diabetes patients in making the right health choices which improves their overall well-being.

Recently, the advancements in technology have complemented the evolution of self monitoring blood glucose strips as more advanced and efficient products have been created. The introduction of Continuous glucose monitoring systems along with smart devices has provided patients with significantly more precise and easier methods of control than traditional testing. Therefore, the self monitoring blood glucose strips market is changing at a rapid pace and offers a lot of new prospects for market players and other interested parties to satisfy the varied requirements of patients.

With the growth of the market, participants in the sector need to know new trends and regulatory shifts and shifts in consumer behavior. The company has well-developed methods that allow us to comprehend the evolution and enable strategic planning targeting the shifting needs of people suffering from diabetes. Industry Insights Verified is determined to help businesses understand value propositions through market research and successfully operate in this complex environment.

 

ATTRIBUTES	DETAILS
STUDY PERIOD	2023-2033
BASE YEAR	2023
FORECAST PERIOD	2024-2033
HISTORICAL PERIOD	2023-2024
UNIT	VALUE (USD BILLION)
KEY COMPANIES PROFILED	Abbott Laboratories, Roche Diabetes Care, Bayer AG, Dexcom Inc., Johnson & Johnson, Medtronic plc, Ascensia Diabetes Care, Siemens Healthineers, Nova Biomedical, Arkray Inc., B. Braun Melsungen AG
SEGMENTS COVERED	By Type - Blood Glucose Test Strips, Continuous Glucose Monitoring (CGM) Strips By End User - Hospitals, Homecare, Diabetes Care Centers, Clinics, Others By Distribution Channel - Online Pharmacies, Retail Pharmacies, Hospital Pharmacies, Others By Geography - North America, Europe, APAC, Middle East Asia & Rest of World.

---

Self-Monitoring Blood Glucose Strips Industry Dynamics

The Self-Monitoring Blood Glucose Strips Industry is undergoing significant changes due to various dynamic factors. This section delves into the key drivers, restraints, opportunities, and challenges that are shaping the market landscape.

Market Drivers

1. Technological Advancements
2. Increasing Consumer Demand
3. Regulatory Support
4. Globalization

Market Restraints

1. High Operational Costs
2. Regulatory Challenges
3. Market Saturation

Market Opportunities

1. Emerging Markets
2. Product Innovation
3. Strategic Partnerships

Market Challenges

1. Technological Disruptions
2. Supply Chain Issues
3. Changing Consumer Preferences

---

Key Players in the Self-Monitoring Blood Glucose Strips Industry

This report provides an in-depth analysis of both established and rising industry participants. It provides broad lists of important companies organized by the types of products they offer and other market-related factors. In addition to characterizing these companies, the report contains the year each player entered the market, which is useful for research analysis by the study's analysts.

• Abbott Laboratories
• Roche Diabetes Care
• Bayer AG
• Dexcom Inc.
• Johnson & Johnson
• Medtronic plc
• Ascensia Diabetes Care
• Siemens Healthineers
• Nova Biomedical
• Arkray Inc.
• B. Braun Melsungen AG

---

Customization Options

Verified Industry Insights offers one of the following report customization options to our respectable clients :

Company Profiling

● Detailed profiling of additional market players (up to three players)
● SWOT analysis of key players (up to three players)

Competitive Benchmarking

● Benchmarking of key players on the following parameters : Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research

Verified Industry Insights offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected] or call us at +1 743 222 5439

© 2024 Verified Industry Insights. All Rights Reserved